FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

ValueSets

83,684 resources

Source: Text:

By Version

By Authority

By Realm

 

Start Prev Rows 48200 - 48400 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmAuthSource(s)
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1623.jsonVisual Field Defectsactive2022-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1626.jsonAmblyopiaactive2021-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1628.jsonAmblyopiaactive2025-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1632.jsonChoroidal Degenerationsactive2025-01ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1634.jsonChoroidal Degenerationsactive2025-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1635.jsonChoroidal Detachmentactive2024-12ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1637.jsonChoroidal Detachmentactive2025-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1638.jsonChoroidal Hemorrhage and Ruptureactive2021-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1640.jsonChoroidal Hemorrhage and Ruptureactive2025-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1641.jsonDegeneration of Macula and Posterior Poleactive2021-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1643.jsonDegeneration of Macula and Posterior Poleactive2025-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1644.jsonDegenerative Disorders of Globeactive2021-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1646.jsonDegenerative Disorders of Globeactive2025-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1647.jsonDiabetic Macular Edemaactive2025-01ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1649.jsonDiabetic Macular Edemaactive2025-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1653.jsonDisorders of Optic Chiasmactive2021-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1655.jsonDisorders of Optic Chiasmactive2025-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1656.jsonDisorders of Visual Cortexactive2021-04ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1658.jsonDisorders of Visual Cortexactive2025-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1659.jsonDisseminated Chorioretinitis and Disseminated Retinochoroiditisactive2021-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1661.jsonDisseminated Chorioretinitis and Disseminated Retinochoroiditisactive2021-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1662.jsonFocal Chorioretinitis and Focal Retinochoroiditisactive2021-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1664.jsonFocal Chorioretinitis and Focal Retinochoroiditisactive2025-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1665.jsonGlaucoma Associated with Congenital Anomalies and Dystrophies and Systemic Syndromesactive2021-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1667.jsonGlaucoma Associated with Congenital Anomalies and Dystrophies and Systemic Syndromesactive2025-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1668.jsonHereditary Choroidal Dystrophiesactive2021-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1670.jsonHereditary Choroidal Dystrophiesactive2025-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1671.jsonHereditary Retinal Dystrophiesactive2024-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1673.jsonHereditary Retinal Dystrophiesactive2025-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1677.jsonNystagmus and Other Irregular Eye Movementsactive2021-03ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1679.jsonNystagmus and Other Irregular Eye Movementsactive2025-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1680.jsonOptic Atrophyactive2021-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1682.jsonOptic Atrophyactive2025-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1683.jsonOptic Neuritisactive2021-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1685.jsonOptic Neuritisactive2022-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1686.jsonOther and Unspecified Forms of Chorioretinitis and Retinochoroiditisactive2021-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1688.jsonOther and Unspecified Forms of Chorioretinitis and Retinochoroiditisactive2025-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1689.jsonOther Background Retinopathy and Retinal Vascular Changesactive2021-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1691.jsonOther Background Retinopathy and Retinal Vascular Changesactive2025-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1695.jsonOther Disorders of Optic Nerveactive2021-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1697.jsonOther Disorders of Optic Nerveactive2025-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1701.jsonOther Endophthalmitisactive2021-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1703.jsonOther Endophthalmitisactive2025-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1707.jsonPrior Penetrating Keratoplastyactive2021-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1709.jsonPrior Penetrating Keratoplastyactive2021-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1713.jsonPurulent Endophthalmitisactive2021-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1715.jsonPurulent Endophthalmitisactive2025-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1716.jsonRetinal Detachment with Retinal Defectactive2022-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1718.jsonRetinal Detachment with Retinal Defectactive2025-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1719.jsonRetinal Vascular Occlusionactive2021-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1721.jsonRetinal Vascular Occlusionactive2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1722.jsonOther Proliferative Retinopathyactive2021-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1724.jsonOther Proliferative Retinopathyactive2025-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1728.jsonSeparation of Retinal Layersactive2021-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1730.jsonSeparation of Retinal Layersactive2025-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1731.jsonVisual Acuity 20/40 or Betteractive2021-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.175.jsonHypotensionactive2017-05ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1752.jsonSpeech and Hearing Evaluationactive2017-05ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.176.jsonArrhythmiaactive2017-05ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1766.jsonMorgagnian Cataractactive2021-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1767.jsonMorgagnian Cataractactive2021-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1769.jsonMacular Scar of Posterior Polaractive2021-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.177.jsonAtrioventricular Blockactive2017-05ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1770.jsonMacular Scar of Posterior Polaractive2025-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1771.jsonOphthalmological Servicesactive2021-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1772.jsonAnnual Wellness Visitactive2024-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1773.jsonSpeech and Hearing Evaluationactive2019-03ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1774.jsonOccupational Therapy Evaluationactive2021-09ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1775.jsonBehavioral Neuropsych Assessmentactive2019-03ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1776.jsonPsych Visit Diagnostic Evaluationactive2020-03ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1777.jsonPsych Visit Psychotherapyactive2019-03ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1778.jsonPsychoanalysisactive2019-03ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1779.jsonGroup Psychotherapyactive2021-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.178.jsonCardiac Pacer in Situactive2017-05ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1780.jsonPsych Visit for Family Psychotherapyactive2021-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1781.jsonBest Corrected Visual Acuity Exam Using Snellen Chartactive2021-02ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.180.jsonHypotensionactive2023-03ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.181.jsonArrhythmiaactive2017-05ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.183.jsonCardiac Pacer in Situactive2021-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.185.jsonHypotensionactive2025-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.186.jsonArrhythmiaactive2025-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.187.jsonAtrioventricular Blockactive2025-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1912.jsonMajor Depressive Disorder Activeactive2023-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1918.jsonMajor Depressive Disorder Activeactive2023-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1923.jsonPsych Visit Diagnostic Evaluationactive2017-05ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1924.jsonCardiac Pacer in Situactive2023-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.408.jsonBradycardiaactive2024-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.410.jsonBradycardiaactive2017-05ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.411.jsonBradycardiaactive2017-05ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.422.jsonTobacco Useractive2024-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.423.jsonTobacco Use Cessation Pharmacotherapyactive2025-01ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.424.jsonTobacco Use Cessation Counselingactive2017-05ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.425.jsonTobacco Use Cessation Counselingactive2023-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.450.jsonPain Warranting Further Investigation for Prostate Canceractive2023-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.469.jsonBilateral Oophorectomyactive2017-09ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.470.jsonBilateral Oophorectomyactive2024-01ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.483.jsonChemotherapyactive2024-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.484.jsonChemotherapyactive2021-08ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.511.jsonTobacco Non Useractive2024-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.532.jsonPregnancyactive2025-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.56.jsonCoronary Artery Disease No MIactive2017-05ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.57.jsonCoronary Artery Disease No MIactive2024-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.58.jsonInitial Myocardial Infarctionactive2024-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.589.jsonEnd Stage Renal Diseaseactive2017-05ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.59.jsonAsthmaactive2017-05ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.590.jsonEnd Stage Renal Diseaseactive2017-05ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.60.jsonAsthmaactive2017-05ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.61.jsonAsthmaactive2025-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.73.jsonPrimary Open Angle Glaucomaactive2021-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.74.jsonPrimary Open Angle Glaucomaactive2025-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.76.jsonDiabetic Retinopathyactive2021-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.80.jsonDiabetic Retinopathyactive2025-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.859.jsonLeft Ventricular Systolic Dysfunctionactive2017-05ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.860.jsonModerate or Severeactive2017-05ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.861.jsonModerate or Severe LVSDactive2017-05ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.91.jsonProstate Canceractive2017-05ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.92.jsonProstate Canceractive2025-03ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1002.jsonChronic Kidney Disease, Stage 5active2020-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1005.jsonDementia and Mental Degenerationsactive2020-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1006.jsonStandardized Tools Score for Assessment of Cognitionactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1007.jsonMedical Reasonactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1008.jsonPatient Reasonactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1010.jsonCanceractive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1011.jsonOccupational Therapy Evaluationactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1012.jsonPatient Provider Interactionactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1018.jsonPsych Visit for Family Psychotherapyactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1023.jsonBehavioral or Neuropsych Assessmentactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1026.jsonRadiation Treatment Managementactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1027.jsonChemotherapy Administrationactive2024-01ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1028.jsonStandardized Pain Assessment Toolactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1090.jsonModerate or Severe LVSDactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1091.jsonLeft Ventricular Systolic Dysfunctionactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1092.jsonModerate or Severeactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1134.jsonEjection Fractionactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1139.jsonACE Inhibitor or ARB or ARNIactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1140.jsonPatient Reason for ACE Inhibitor or ARB Declineactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1141.jsonPsychoanalysisactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1151.jsonRenal Failure Due to ACE Inhibitoractive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1170.jsonTobacco Useractive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1174.jsonBeta Blocker Therapyactive2021-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1176.jsonHeart Rateactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1177.jsonAllergy to Beta Blocker Therapyactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1178.jsonIntolerance to Beta Blocker Therapyactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1184.jsonBeta Blocker Therapy for LVSDactive2017-05ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1187.jsonGroup Psychotherapyactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1189.jsonTobacco Non Useractive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1190.jsonTobacco Use Cessation Pharmacotherapyactive2017-05ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1193.jsonCardiac Paceractive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1211.jsonAllergy to ACE Inhibitor or ARBactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1212.jsonIntolerance to ACE Inhibitor or ARBactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1240.jsonAnnual Wellness Visitactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1241.jsonAcute and Subacute Iridocyclitisactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1251.jsonMacular Examactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1259.jsonLimited Life Expectancyactive2025-04ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1278.jsonTobacco Use Screeningactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1283.jsonLevel of Severity of Retinopathy Findingsactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1285.jsonOphthalmological Servicesactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1320.jsonMacular Edema Findings Presentactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1332.jsonCognitive Assessmentactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1333.jsonCup to Disc Ratioactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1334.jsonOptic Disc Exam for Structural Abnormalitiesactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1409.jsonBurn Confined to Eye and Adnexaactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1410.jsonCataract Secondary to Ocular Disordersactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1411.jsonCataract Surgeryactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1412.jsonCataract Congenitalactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1413.jsonCataract Mature or Hypermatureactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1414.jsonCataract Posterior Polaractive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1415.jsonCertain Types of Iridocyclitisactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1416.jsonChronic Iridocyclitisactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1417.jsonCloudy Corneaactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1418.jsonCorneal Edemaactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1419.jsonDisorders of Cornea Including Corneal Opacityactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1423.jsonGlaucomaactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1424.jsonHereditary Corneal Dystrophiesactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1426.jsonHypotony of Eyeactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1427.jsonInjury to Optic Nerve and Pathwaysactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1428.jsonCentral Corneal Ulceractive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1430.jsonOpen Wound of Eyeballactive2021-04ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1432.jsonPathologic Myopiaactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1433.jsonPosterior Lenticonusactive2021-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1438.jsonRetrolental Fibroplasiasactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1443.jsonTraumatic Cataractactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1444.jsonUveitisactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1445.jsonVascular Disorders of Iris and Ciliary Bodyactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1446.jsonVisual Field Defectsactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1448.jsonAmblyopiaactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1450.jsonChoroidal Degenerationsactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1451.jsonChoroidal Detachmentactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1452.jsonChoroidal Hemorrhage and Ruptureactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1453.jsonDegeneration of Macula and Posterior Poleactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1454.jsonDegenerative Disorders of Globeactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1455.jsonDiabetic Macular Edemaactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1457.jsonDisorders of Optic Chiasmactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1458.jsonDisorders of Visual Cortexactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1459.jsonDisseminated Chorioretinitis and Disseminated Retinochoroiditisactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1460.jsonFocal Chorioretinitis and Focal Retinochoroiditisactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1461.jsonGlaucoma Associated with Congenital Anomalies and Dystrophies and Systemic Syndromesactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1462.jsonHereditary Choroidal Dystrophiesactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1463.jsonHereditary Retinal Dystrophiesactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1465.jsonNystagmus and Other Irregular Eye Movementsactive2021-03ushl7vsac